Somewhat Favorable Press Coverage Somewhat Unlikely to Affect Cognex (CGNX) Share Price

Media stories about Cognex (NASDAQ:CGNX) have trended somewhat positive this week, Accern reports. The research group identifies negative and positive press coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Cognex earned a media sentiment score of 0.17 on Accern’s scale. Accern also gave headlines about the scientific and technical instruments company an impact score of 47.2518365383606 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

These are some of the headlines that may have impacted Accern Sentiment’s scoring:

Shares of Cognex stock opened at $46.34 on Wednesday. Cognex has a 1 year low of $39.90 and a 1 year high of $72.99. The company has a market cap of $7.86 billion, a P/E ratio of 31.96 and a beta of 1.61.

Cognex (NASDAQ:CGNX) last issued its quarterly earnings data on Monday, April 30th. The scientific and technical instruments company reported $0.21 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.20 by $0.01. Cognex had a return on equity of 23.08% and a net margin of 21.56%. The firm had revenue of $169.57 million during the quarter, compared to the consensus estimate of $170.93 million. During the same period in the previous year, the firm posted $0.25 EPS. The company’s quarterly revenue was up 22.0% compared to the same quarter last year. analysts predict that Cognex will post 1.15 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 1st. Investors of record on Friday, May 18th will be given a dividend of $0.045 per share. The ex-dividend date of this dividend is Thursday, May 17th. This represents a $0.18 annualized dividend and a dividend yield of 0.39%. Cognex’s dividend payout ratio is currently 12.41%.

Cognex declared that its Board of Directors has initiated a stock buyback program on Thursday, February 15th that authorizes the company to buyback $150.00 million in shares. This buyback authorization authorizes the scientific and technical instruments company to purchase shares of its stock through open market purchases. Stock buyback programs are generally a sign that the company’s board of directors believes its stock is undervalued.

Several brokerages have recently commented on CGNX. Zacks Investment Research lowered Cognex from a “buy” rating to a “sell” rating in a research note on Wednesday, May 2nd. ValuEngine lowered Cognex from a “sell” rating to a “strong sell” rating in a research note on Tuesday. JPMorgan Chase decreased their price target on Cognex from $62.50 to $42.00 and set a “hold” rating on the stock in a research note on Tuesday, May 1st. Robert W. Baird decreased their price target on Cognex from $62.00 to $40.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 1st. Finally, BidaskClub lowered Cognex from a “sell” rating to a “strong sell” rating in a research note on Thursday, April 26th. Four investment analysts have rated the stock with a sell rating, three have given a hold rating and five have assigned a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $57.21.

In related news, Director Anthony Sun sold 10,000 shares of Cognex stock in a transaction that occurred on Monday, March 12th. The stock was sold at an average price of $56.49, for a total transaction of $564,900.00. Following the completion of the transaction, the director now directly owns 294,262 shares in the company, valued at approximately $16,622,860.38. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 5.40% of the company’s stock.

About Cognex

Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate tasks primarily in manufacturing processes worldwide. The company offers machine vision products, which are used to automate the manufacturing and tracking of discrete items, such as mobile phones, aspirin bottles, and automobile tires by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.

Insider Buying and Selling by Quarter for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with's FREE daily email newsletter.

Leave a Reply